Antibiotic Usage: Pharmacoeconomic Impact in a Changing Healthcare System View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1996-08

AUTHORS

Gary Milkovich

ABSTRACT

There is limited experience in the healthcare field in terms of the evaluation of treatment costs. All too often, healthcare providers focus on the financial end-points (such as drug acquisition costs) as opposed to clinical end-points. This approach fails to view products from a broader perspective and tends to ignore the impact of a drug in terms of better patient compliance, fewer office visits, reduced length of hospital stay, or avoidance of hospitalisation. This article will briefly discuss the techniques used in the US to improve the utilisation of antibiotics, and describe the move towards the use of outpatient (i.e. outpatient care attached to a hospital, or in an infusion or clinic setting) or home therapy. More... »

PAGES

80-82

Identifiers

URI

http://scigraph.springernature.com/pub.10.2165/00003495-199600522-00016

DOI

http://dx.doi.org/10.2165/00003495-199600522-00016

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1005174174

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/8869842


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Bacterial Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cost-Benefit Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Costs and Cost Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Delivery of Health Care", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Utilization", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United States", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Inova Alexandria Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413592.8", 
          "name": [
            "Alexandria Hospital Pharmacy Department, Alexandria Hospital, 4320 Seminary Road, 22304, Alexandria, Virginia, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Milkovich", 
        "givenName": "Gary", 
        "id": "sg:person.0650425672.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650425672.66"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1996-08", 
    "datePublishedReg": "1996-08-01", 
    "description": "There is limited experience in the healthcare field in terms of the evaluation of treatment costs. All too often, healthcare providers focus on the financial end-points (such as drug acquisition costs) as opposed to clinical end-points. This approach fails to view products from a broader perspective and tends to ignore the impact of a drug in terms of better patient compliance, fewer office visits, reduced length of hospital stay, or avoidance of hospitalisation. This article will briefly discuss the techniques used in the US to improve the utilisation of antibiotics, and describe the move towards the use of outpatient (i.e. outpatient care attached to a hospital, or in an infusion or clinic setting) or home therapy.", 
    "genre": "research_article", 
    "id": "sg:pub.10.2165/00003495-199600522-00016", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1084788", 
        "issn": [
          "0012-6667", 
          "1179-1950"
        ], 
        "name": "Drugs", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "Suppl 2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "52"
      }
    ], 
    "name": "Antibiotic Usage: Pharmacoeconomic Impact in a Changing Healthcare System", 
    "pagination": "80-82", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "18a6bc9855e27d3f31994360264feef6955ccf21e81e11dc7231cbe304fefc36"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "8869842"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7600076"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.2165/00003495-199600522-00016"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1005174174"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.2165/00003495-199600522-00016", 
      "https://app.dimensions.ai/details/publication/pub.1005174174"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T16:00", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8664_00000569.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.2165/00003495-199600522-00016"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.2165/00003495-199600522-00016'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.2165/00003495-199600522-00016'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.2165/00003495-199600522-00016'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.2165/00003495-199600522-00016'


 

This table displays all metadata directly associated to this object as RDF triples.

97 TRIPLES      20 PREDICATES      36 URIs      28 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.2165/00003495-199600522-00016 schema:about N0055cb6c80274799973254ce354779aa
2 N46e1c073a94e4962a760b76f9503b915
3 N5db8dd47917748cc9066a3157d96a819
4 N897297a46acf44e4b922dd0aebd8b310
5 Nb8908d879ec74d239c3d6f9e867a8db4
6 Ncd59001398e24ea3935fdf28979d97d9
7 Nf9f500354c0c46e090aed7fca34632fa
8 anzsrc-for:11
9 anzsrc-for:1117
10 schema:author Nf907401cbf0a4edcb8cbacd2228d07ff
11 schema:datePublished 1996-08
12 schema:datePublishedReg 1996-08-01
13 schema:description There is limited experience in the healthcare field in terms of the evaluation of treatment costs. All too often, healthcare providers focus on the financial end-points (such as drug acquisition costs) as opposed to clinical end-points. This approach fails to view products from a broader perspective and tends to ignore the impact of a drug in terms of better patient compliance, fewer office visits, reduced length of hospital stay, or avoidance of hospitalisation. This article will briefly discuss the techniques used in the US to improve the utilisation of antibiotics, and describe the move towards the use of outpatient (i.e. outpatient care attached to a hospital, or in an infusion or clinic setting) or home therapy.
14 schema:genre research_article
15 schema:inLanguage en
16 schema:isAccessibleForFree false
17 schema:isPartOf N89d31ec85c134af38767dd27468aad9c
18 N990507b0edc74865b14011f83d92adbc
19 sg:journal.1084788
20 schema:name Antibiotic Usage: Pharmacoeconomic Impact in a Changing Healthcare System
21 schema:pagination 80-82
22 schema:productId N386e12c2d8e84f8897eb70a904fa356b
23 N688e2cf79783444a99ebd588007937f9
24 N6a177afb80d64d3d92fb862f3684631b
25 Nb06427bb3bf0428093cb9f96d73a3fc9
26 Ncc5a5a05d14b4658932799bcd6963503
27 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005174174
28 https://doi.org/10.2165/00003495-199600522-00016
29 schema:sdDatePublished 2019-04-10T16:00
30 schema:sdLicense https://scigraph.springernature.com/explorer/license/
31 schema:sdPublisher N10d4be16a9694de098e67cabec0a7e77
32 schema:url http://link.springer.com/10.2165/00003495-199600522-00016
33 sgo:license sg:explorer/license/
34 sgo:sdDataset articles
35 rdf:type schema:ScholarlyArticle
36 N0055cb6c80274799973254ce354779aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
37 schema:name Delivery of Health Care
38 rdf:type schema:DefinedTerm
39 N10d4be16a9694de098e67cabec0a7e77 schema:name Springer Nature - SN SciGraph project
40 rdf:type schema:Organization
41 N386e12c2d8e84f8897eb70a904fa356b schema:name nlm_unique_id
42 schema:value 7600076
43 rdf:type schema:PropertyValue
44 N46e1c073a94e4962a760b76f9503b915 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
45 schema:name United States
46 rdf:type schema:DefinedTerm
47 N5db8dd47917748cc9066a3157d96a819 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
48 schema:name Humans
49 rdf:type schema:DefinedTerm
50 N688e2cf79783444a99ebd588007937f9 schema:name pubmed_id
51 schema:value 8869842
52 rdf:type schema:PropertyValue
53 N6a177afb80d64d3d92fb862f3684631b schema:name doi
54 schema:value 10.2165/00003495-199600522-00016
55 rdf:type schema:PropertyValue
56 N897297a46acf44e4b922dd0aebd8b310 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
57 schema:name Cost-Benefit Analysis
58 rdf:type schema:DefinedTerm
59 N89d31ec85c134af38767dd27468aad9c schema:volumeNumber 52
60 rdf:type schema:PublicationVolume
61 N990507b0edc74865b14011f83d92adbc schema:issueNumber Suppl 2
62 rdf:type schema:PublicationIssue
63 Nb06427bb3bf0428093cb9f96d73a3fc9 schema:name dimensions_id
64 schema:value pub.1005174174
65 rdf:type schema:PropertyValue
66 Nb8908d879ec74d239c3d6f9e867a8db4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Anti-Bacterial Agents
68 rdf:type schema:DefinedTerm
69 Ncc5a5a05d14b4658932799bcd6963503 schema:name readcube_id
70 schema:value 18a6bc9855e27d3f31994360264feef6955ccf21e81e11dc7231cbe304fefc36
71 rdf:type schema:PropertyValue
72 Ncd59001398e24ea3935fdf28979d97d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Drug Utilization
74 rdf:type schema:DefinedTerm
75 Nf907401cbf0a4edcb8cbacd2228d07ff rdf:first sg:person.0650425672.66
76 rdf:rest rdf:nil
77 Nf9f500354c0c46e090aed7fca34632fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Costs and Cost Analysis
79 rdf:type schema:DefinedTerm
80 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
81 schema:name Medical and Health Sciences
82 rdf:type schema:DefinedTerm
83 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
84 schema:name Public Health and Health Services
85 rdf:type schema:DefinedTerm
86 sg:journal.1084788 schema:issn 0012-6667
87 1179-1950
88 schema:name Drugs
89 rdf:type schema:Periodical
90 sg:person.0650425672.66 schema:affiliation https://www.grid.ac/institutes/grid.413592.8
91 schema:familyName Milkovich
92 schema:givenName Gary
93 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650425672.66
94 rdf:type schema:Person
95 https://www.grid.ac/institutes/grid.413592.8 schema:alternateName Inova Alexandria Hospital
96 schema:name Alexandria Hospital Pharmacy Department, Alexandria Hospital, 4320 Seminary Road, 22304, Alexandria, Virginia, USA
97 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...